e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
New data on established treatments for COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study
Roberto Walter Dal Negro (Verona, Italy), Roberto W. Dal Negro, Martin Iversen, Peter M.A. Calverly
Source:
International Congress 2015 – New data on established treatments for COPD
Session:
New data on established treatments for COPD
Session type:
Poster Discussion
Number:
1495
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Roberto Walter Dal Negro (Verona, Italy), Roberto W. Dal Negro, Martin Iversen, Peter M.A. Calverly. Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study. Eur Respir J 2015; 46: Suppl. 59, 1495
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Real-life study on the aPpropriaTeness of treatment in moderate COPD patients (OPTIMO)
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Short-term telemonitoring program after hospital discharge for COPD exacerbation: Greek pilot of the renewing health multicenter randomized trial
Source: International Congress 2015 – Tele-rehabilitation in chronic lung diseases
Year: 2015
Safety and effectiveness of indacaterol in Korean COPD patients: A post-marketing surveillance (PMS) study
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015
Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study
Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical)
Year: 2014
Effect of telehealthcare on exacerbations and hospital admissions in COPD: A randomised controlled trial
Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2015
Costs and effects of structured COPD care – An observational, matched-cohort study
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013
Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT)
Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2015
Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
QVA149 reduces the risk of moderate-to-severe exacerbations compared with open-label tiotropium in patients with severe COPD: The SPARK study
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Roflumilast for stable COPD: Meta-analysis of randomized controlled trials
Source: International Congress 2014 – Clinical presentations
Year: 2014
One-year efficacy of aclidinium/formoterol fixed-dose combination in COPD patients: The AUGMENT COPD study
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014
Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability
Source: International Congress 2014 – Markers
Year: 2014
The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Telehealthcare in COPD – A feasibility trial
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016
Estimation of tiotropium efficacy at the COPD patients with group D
Source: International Congress 2015 – Different data in COPD
Year: 2015
Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept